Collaborating for Cures-Leveraging Global Public-Private Partnerships to Accelerate Medical Product Development
7 March 2013, Brussels
The Innovative Medicines Initiative (IMI) and Critical Path Institute (C-Path) will hold a joint event on the challenges and opportunities of public-private partnerships (PPPs).
This first ever public conference co-sponsored by IMI and C-Path will feature cross-sector participants discussing challenges and opportunities in the rapidly-evolving PPP space. The objective is to identify mechanisms for enhancing the productivity of PPPs, coordinating individual PPP efforts to avoid duplication, and adopting best practices on data sharing, intellectual property, and other cross-cutting issues in order to streamline medical product development world-wide.